维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="COLUCCIA AM"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60 (c-Src) -dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling显示文摘	Coluccia AM Benati D Dekhil H	2006	Cancer Res2006，66，4：	1
	2	Mutation-independent anaplastic lymphoma kinase overex-pression in poor prognosis neuroblastoma patients显示文摘	Passoni L Longo L Collini P Coluccia AM Bozzi F Podda M	2009	CancerRes2009，69，18：	1
	3	Constitutive activation of Jak2 contributes to proliferation and resistance toapoptosls in NPM/ALK-transformed cells 显示文摘	Ruchatz H Coluccia AM Stano P	2003	Exp Hematol2003，31，4：	1
	4	SKI-606 decreases growth and motility of colorectat cancer cells by preventing pp60(c -Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling显示文摘	Coluccia AM Benati D Dekhil H	2006	Cancer Res2006，66，4：	1
	5	Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK - transformed cells显示文摘	Ruchatz H Coluccia AM Stano P	2003	Exp Hematol2003，31，4：	1
	6	Bcl-XL downregulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo显示文摘	Coluccia AM Perego S Cleris L	2004	Blood2004，103，7：	1
	7	Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells显示文摘	Ruchatz H Coluccia AM Stano P	2003	Exp Hematol2003，31，4：	1
	8	Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo 显示文摘	Coluccia AM Perego S Cleris L Gunby RH Passoni L Marchesi E	2004	Blood2004，103，7：	1
	9	Bcr-Abl stabilizes beta- catenin in chronic myeloid leukemia through its tyrosine phosphoryl- ation显示文摘	Coluccia AM Vacca A Dufiach M	2007	EMBO J2007，26，5：	1
	10	In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against ima- tlnib-resistant Bcr-Abl + neoplastic cells 显示文摘	PUTTINI M COLUCCIA AM BOSCHELLI F	2006	Cancer Res2006，66，11：	1
	11	Validation of PDGFR beta and c-Src tyrosinc kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib显示文摘	Coluccia AM Cinllli T Neri P	2008	Blood2008，112，：	1
	12	Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma显示文摘	De Luisi A Ferrucci A Coluccia AM		0，，7：	1
	13	Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma:preclinical efficacy of the novel,orally available inhibitor dasatinib显示文摘	Coluccia AM Cirulli T Neri P	2008	{H}Blood2008，，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费